Personalized Dietary Feedback to Reduce Hepatic Steatosis in Patients With MASLD
NCT07914829, Not applicable, Not yet recruiting, Medical University of Vienna
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Personalized Dietary Feedback to Reduce Hepatic Steatosis in Patients With MASLD | ClinicalTrials.gov |
| NCT number | NCT07914829 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 174 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Medical University of Vienna | ClinicalTrials.gov |
| Conditions | MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), MetALD, Steatotic Liver Disease | ClinicalTrials.gov |
| Interventions | Personalized Dietary Feedback, Generic Dietary Feedback | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Hepatic Steatosis at 6 Months, Assessed by Controlled Attenuation Parameter (CAP) Using Vibration-Controlled Transient Elastography (VCTE) | 6 months (baseline CAP used for adjustment). | Hepatic steatosis will be quantified using the controlled attenuation parameter (CAP), measured in decibels per meter (dB/m) by vibration-controlled transient elastography (VCTE). The outcome measure is the CAP value at 6 months. The between-group difference at 6 months will be evaluated using analysis of covariance (ANCOVA), with baseline CAP included as a covariate. CAP is the only measurement reported for this outcome. | ClinicalTrials.gov |
| Secondary | Change in Body Weight from Baseline to 6 Months | Baseline and 6 months | Body weight will be measured in kilograms (kg). Change will be calculated as body weight at 6 months minus baseline body weight. | ClinicalTrials.gov |
| Secondary | Percentage Change in Body Weight from Baseline to 6 Months | Baseline and 6 months | Percentage change in body weight will be calculated as \[(body weight at 6 months - baseline body weight) / baseline body weight\] × 100. | ClinicalTrials.gov |
| Secondary | Change in Waist Circumference from Baseline to 6 Months | Baseline and 6 months | Waist circumference will be measured in centimeters (cm). Absolute change from baseline to 6 months will be reported. | ClinicalTrials.gov |
| Secondary | Change in Hip Circumference from Baseline to 6 Months | Baseline and 6 months | Hip circumference will be measured in centimeters (cm). Absolute change from baseline to 6 months will be reported. | ClinicalTrials.gov |
| Secondary | Change in Alanine Aminotransferase (ALT) from Baseline to 6 Months | Baseline and 6 months | Serum ALT will be measured in units per liter (U/L). Absolute change from baseline to 6 months will be reported. | ClinicalTrials.gov |
| Secondary | Change in Aspartate Aminotransferase (AST) from Baseline to 6 Months | Baseline and 6 months | Serum AST will be measured in units per liter (U/L). Absolute change from baseline to 6 months will be reported. | ClinicalTrials.gov |
| Secondary | Change in Gamma-Glutamyl Transferase (GGT) from Baseline to 6 Months | Baseline and 6 months | Serum GGT will be measured in units per liter (U/L). Absolute change from baseline to 6 months will be reported. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)